Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy
Authors:
- Maurice RedondoMRMaurice Redondo
- Friedgard JulmyFJFriedgard Julmy
- Walter A WuilleminWWWalter A Wuillemin
- Mathias U GebauerMGMathias U Gebauer
- André HaeberliAHAndré Haeberli
- Beat J MeyerBMBeat J Meyer
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Prior aspirin use predicts worse outcomes in patients with non–ST-elevation acute coronary syndromes11This study was sponsored by COR Therapeutics Inc., South San Francisco, California; and Schering-Plough Research Institute, Kenilworth, New Jersey.The American Journal of Cardiology, 1999
- Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trialJACC, 1999
- A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery StentingNew England Journal of Medicine, 1998
- Mechanisms of Cerebrovascular Events as Assessed by Procoagulant Activity, Cerebral Microemboli, and Platelet Microparticles in Patients With Prosthetic Heart ValvesStroke, 1998
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996
- Platelet Activation and Coronary Stent ImplantationCirculation, 1996
- A Randomized Comparison of Antiplatelet and Anticoagulant Therapy after the Placement of Coronary-Artery StentsNew England Journal of Medicine, 1996
- Platelet Function in Acute Myocardial Infarction Treated With Direct AngioplastyCirculation, 1996
- Antiplatelet DrugsDrugs, 1995
- Platelet activation by thrombin can be directly measured in whole blood through the use of the peptide GPRP and flow cytometryBlood Coagulation & Fibrinolysis, 1994